Kūlmedis - Company finances
|
EUR
|
2018
From: 2018-03-26
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 116,323 | 136,053 | 86,082 | 48,281 |
| Profit before tax | 0 | 0 | 0 | 0 | 27,915 | -38,702 | 8,650 | 4,345 |
| Net profit | 0 | 0 | 0 | 0 | 26,519 | -38,702 | 8,650 | 4,345 |
| Equity | 0 | 0 | 0 | 0 | 26,519 | -12,183 | -3,533 | 812 |
| Liabilities | - | - | - | - | 14,006 | 41,492 | 37,048 | 50,159 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 7,167 | 5,017 |
| Current assets | 0 | 0 | 0 | 0 | 40,525 | 29,309 | 26,348 | 45,954 |
| Total assets | 0 | 0 | 0 | 0 | 40,525 | 29,309 | 33,515 | 50,971 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +17.0% | -36.7% | -43.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 65.4% | -132.0% | 25.8% | 8.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 100.0% | - | - | 535.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 22.8% | -28.4% | 10.0% | 9.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 24.0% | -28.4% | 10.0% | 9.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.5 | - | - | 61.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 116,323 | 136,053 | 86,082 | 41,383 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kūlmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-11 | 2026-05-14 | 225.34 |
| 2026-05-05 | 2026-05-10 | 553.20 |
| 2024-07-02 | 2024-07-31 | 129.00 |
| 2024-06-03 | 2024-07-01 | 64.50 |
| 2023-11-16 | 2023-11-20 | 30.77 |
| 2023-07-18 | 2023-07-23 | 89.04 |
| 2023-04-03 | 2023-04-05 | 58.63 |
| 2023-03-01 | 2023-03-06 | 58.63 |
| 2023-02-06 | 2023-02-12 | 58.63 |
| 2023-02-01 | 2023-02-03 | 58.63 |
| 2022-12-01 | 2022-12-06 | 50.95 |
| 2022-06-01 | 2022-06-30 | 254.75 |
| 2022-05-03 | 2022-05-31 | 203.80 |
| 2022-04-29 | 2022-05-02 | 152.85 |
| 2022-04-25 | 2022-04-28 | 376.90 |
Kūlmedis - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kulmedis, MB (company code 304808861) is a small partnership operating in repair and renovation of buildings. In 2025, the company generated revenue of €48.3K and net profit of €4.3K, corresponding to a 9.0% profit margin. Revenue declined by 43.9% year on year and by 64.5% compared with 2023, showing a clear contraction after a stronger earlier base. The multi-year trend moved from a 2023 loss of €38.7K on revenue of €136.1K and a negative margin of 28.4%, to a profit of €8.7K in 2024 on revenue of €86.1K, and then to a smaller but still positive result in 2025. At the end of 2025, total assets stood at €51.0K, equity at €812, and liabilities at €50.2K, indicating a highly leveraged balance sheet with an equity ratio of 1.6%. Asset turnover was 0.95x. Revenue per employee was €48.3K and profit per employee was €4.3K.